Wuhan Greenovo Biotechnology Co., Ltd
Keywords : artery compression hemostat
Description : Wuhan Greenovo biotechnology Co., LTD is a new type of biomedical materials research, development, production and marketing of high-tech enterprise.Unlike other hemostatic devices, Greenovo products are impregnated with kaolin, a naturally occurring, inorganic mineral (clay derivative).Kaolin has no known allergic or exothermic reactions. Greenovo products are safe and effective, having passed all biocompatibility testing, and do not contain any animal or human-derived proteins or shellfish products.Greenovo is the essential choice for hemorrhage control in a broad range of bleeding situations.
1, Unique material processing patent technology：Greenovo has researched and developed to establish a set of internationally advanced technology in the production, purification and molding of chitin through the cooperation with chitin research and development center of Wuhan University and Northwestern University Center for biomedical.The technology can control and protect products from the source.
2, International standard GMP factory ：Greenovo owns 1278 square meters purification workshop which can meet the requirements of the international GMP.It has got two high purity of chitin raw materials production lines and eight chitin products molding production lines with the SFDA national class ii and class iii medical equipment production licenses.
3, Patent technology, the comprehensive protection of intellectual property : Greenovo owns 12 invention patents, and 4 of them are national invention patents.
4, The most comprehensive product line layout, positioning every segment of wound care: Greenovo has five medical equipment product registration certificate, forming the first aid hemostasis, intraoperative bleeding, dental bleeding, wound care, home care, five fields and more than 50 product rules medical product layout, which makes greenovo the unique domestic enterprises presently that the products can fully meet the diverse needs of wound care of biological pharmaceutical. |
